A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

NCT00240448 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1109

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: telmisartan 80 mg/hydrochlorothiazide 25 mg
DRUG: valsartan 160 mg/hydrochlorothiazide 25 mg
DRUG: placebo

Sponsor

Boehringer Ingelheim